CVS to Cover Lilly’s GLP-1 Medications, Expanding Access
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
A financial planner can help you navigate retirement planning, ensuring you have the right strategies in place for a secure future.
25,466 articlesCVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Canadian travel has cooled as cross-border tensions and higher fuel prices curb bookings for Maine inns and regional ...
A Nike brand moat argument resurfaces as investors weigh the stock's downside and potential upside. A Nike analyst po...
A fresh investing approach uncovers lesser-known AI stock ideas beyond the marquee names, highlighting software platf...
Bitcoin price craters $60,000 after the May U.S. jobs report, as traders reassess Federal Reserve easing bets. Crypto...
Strategy has restarted bitcoin purchases, acquiring 1,550 BTC for about $101 million and lifting its total BTC stash ...
The Amplify Seymour Cannabis ETF (CNBS) is up 105% over the past year, driven by investor bets on federal cannabis re...
Bitcoin remains resilient as ETF outflows accelerate and geopolitical headlines swirl. A new Chainlink-Kraken World C...
Oracle confronts a fresh wave of investor anxiety as a heavy OpenAI backlog, negative cash flow, and mounting leverag...
Oil prices retreat toward the $80 level after news of an Iran framework, easing supply fears and rekindling expectati...
Analysts rolled out a fresh slate of calls on Block, Cognizant, First Solar and others as markets navigate midweek vo...
MBA data show a pullback in new home purchase applications in May as mortgage costs remained elevated. The trend unde...